The United Kingdom (UK) has left the European Economic Area (EEA) single market and customs union. This has resulted in regulatory changes in the UK, including some that apply to the movement of human tissues and cells between Great Britain (GB), Northern Ireland (NI), and the EEA.

Establishments importing or exporting human tissues and cells intended for human application (patient treatment) may require a HTA licence covering these activities.